Henkel's latest pro hair-care acquisition, Shiseido's North American-focused Zotos business, boosts its regional market share ahead of former leader Coty. Meanwhile, Revlon reports "disappointing" third-quarter results, and market researcher NPD trumpets the return to growth of "age specialist" skin-care products.

Coty Inc. recorded a $316.9 million asset write-down in the third fiscal quarter related to its TJoy skin-care business in China, driving a $253.3 million loss overall. The firm will reorganize its mass-market business in the country to improve profitability in Skin & Body Care, which booked an 8% increase in global revenues on the strength of the firm’s philosophy brand, among other highlights, despite TJoy’s drag on the segment’s performance.

The French drugmaker is paying $2.5bn to get hold of THOR-707 which it claims has the potential to become the best-in-class IL-2 therapeutic for solid tumors, thanks to improved pharmacology and less frequent dosing.